Bruce & Co., Inc. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 17 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bruce & Co., Inc. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$11,068,000
+52.8%
11,500,0000.0%2.07%
+48.4%
Q4 2020$7,245,0000.0%11,500,0000.0%1.40%
-6.9%
Q3 2020$7,245,000
-3.1%
11,500,0000.0%1.50%
-7.7%
Q2 2020$7,475,000
-25.3%
11,500,0000.0%1.62%
-29.5%
Q1 2020$10,005,000
+15.0%
11,500,0000.0%2.30%
+35.8%
Q4 2019$8,700,000
+107.1%
11,500,000
+91.7%
1.70%
+94.6%
Q3 2019$4,200,0006,000,0000.87%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
SYMPHONY ASSET MANAGEMENT LLC 23,872,000$18,748,0004.04%
PFM Health Sciences, LP 49,764,825$39,319,0001.16%
Partner Investment Management, L.P. 659,175$521,0000.89%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 40,000,000$31,402,000,0000.87%
Bruce & Co., Inc. 6,000,000$4,200,0000.87%
CANYON CAPITAL ADVISORS LLC 36,500,000$28,747,0000.62%
PenderFund Capital Management Ltd. 2,000,000$1,571,0000.53%
Shaolin Capital Management LLC 4,000,000$3,136,0000.48%
Castle Creek Arbitrage, LLC 2,310,000$1,815,0000.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$4,368,0000.27%
View complete list of ACORDA THERAPEUTICS INC shareholders